Ibaraki, Japan

Tatsushi Wakayama

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 2018-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Tatsushi Wakayama

Introduction

Tatsushi Wakayama is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antisense nucleic acids. With a total of two patents to his name, Wakayama's work focuses on advancing medical treatments for genetic disorders.

Latest Patents

Wakayama's latest patents include a groundbreaking drug that allows for the highly-efficient skipping of exon 51 in the human dystrophin gene. This invention provides an antisense oligomer that enables the skipping of exon 51, which is crucial for addressing certain genetic conditions.

Career Highlights

Throughout his career, Tatsushi Wakayama has worked with prominent organizations such as Nippon Shinyaku Company, Ltd. and the National Center of Neurology and Psychiatry. His experience in these institutions has contributed to his expertise in the field of genetic research and drug development.

Collaborations

Wakayama has collaborated with several professionals in his field, including Haruna Seo and Youhei Satou. These partnerships have enhanced his research and innovation efforts.

Conclusion

Tatsushi Wakayama's contributions to biotechnology and his innovative patents demonstrate his commitment to advancing medical science. His work continues to impact the field positively, paving the way for future developments in genetic therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…